Michael Welch

Michael Welch has a diverse work experience in the field of scientific research and development. Michael is currently working at Aligos Therapeutics as a Scientist 2 in Process Development, a position they have held since February 2022. Prior to this role, they were a Scientist in Process Development at the same company from May 2019 to February 2022.

Before joining Aligos Therapeutics, Michael worked at Synterys, Inc. as a Chemist from November 2018 to April 2019. Michael also gained experience at Nitto Denko Technical Corporation, where they held the positions of Senior Staff Scientist from April 2018 to June 2018, Staff Scientist from March 2017 to April 2018, and Synthesis Chemist from July 2016 to March 2017.

Earlier in their career, Michael worked at Alios BioPharma as an Associate Scientist from February 2014 to November 2014, and as a Research Associate from February 2012 to January 2014. Michael also had contract positions at Theravance as a Contractor in Process Chemistry from October 2011 to February 2012, and in Medicinal Chemistry from January 2011 to November 2011.

Michael's earliest work experience was at Roche Palo Alto, where they held various roles. Michael was a Research Scientist from 2008 to 2010, a Research Associate from 2005 to 2008, a Research Associate II from 2002 to 2005, and a Research Associate I from 1999 to 2002.

Throughout their career, Michael Welch has gained expertise in process development, chemistry, synthesis, and scientific research.

Michael Welch obtained a Bachelor of Science (B.S.) degree in Chemistry from William & Mary, where they studied from 1991 to 1995. Michael then pursued their education further and earned a Master of Science (M.S.) degree in Organic Chemistry from The University of Georgia, attending from 1996 to 1999.